Minerva Neurosciences, Inc. (NERV)

NASDAQ

$2,54

$-0,31

(-10,73%)

Regular Market

Minerva Neurosciences, Inc. (NERV) Live Price Chart

Last updated: ⁦2026-10-13 17:25:40⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Minerva Neurosciences, Inc. (NERV) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $2,54, with a market capitalisation of $151,84M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $2,24 to $12,46. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$151,84M
Open	$2,88
Day's High	$126,72
Day's Low	$1,15
Previous Close	$2,89
Volume	101,51K
Average Volume	182,00K
P/E Ratio	--
52-Week High	$12,46
52-Week Low	$2,24
Dividend Yield	--
Earnings Date	--

Minerva Neurosciences, Inc. (NERV) Stock Price Today

Minerva Neurosciences, Inc. (NERV) is currently trading at $2,54 as of 2026-10-13 17:23:00, down 12,11% ($0,35) from the previous close of $2,89

During today's regular trading session, NERV has traded between $1,15 and $126,72, with a trading volume of 101,51K shares. The current price is near the lower end of today's range.

Minerva Neurosciences, Inc. (NERV) 7-Day Stock Price Change

Over the past seven days, Minerva Neurosciences, Inc. (NERV) moved from $3,28 to $2,54, representing a decline of 22,56% ($0,74).

The stock traded between $2,52 and $3,56 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 108,86 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

NERV 52-Week Price Position

Position in Range: 3,0%

52W Low$2,24

52W High$12,46

NERV is currently trading at $2,54, placing it 3,0% of the way from its 52-week low of $2,24 to its 52-week high of $12,46. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Minerva Neurosciences, Inc. (NERV)?

Minerva Neurosciences Inc a clinical-stage biopharmaceutical company focused on the development and commercialization of certain proprietary product candidates to treat patients suffering from central nervous system (CNS) diseases. Its product candidate, Roluperidone, is in development for the treatment of negative symptoms in patients diagnosed with schizophrenia. Its Clinical-Stage Programs include Roluperidone and Seltorexant. The company's operations are organized into one operating and reportable segment focused on the development and commercialization of proprietary product candidates to treat patients suffering from CNS diseases.

Minerva Neurosciences, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	7
Exchange	NASDAQ
Company Website	https://www.minervaneurosciences.com

How to Buy Minerva Neurosciences, Inc. (NERV) Stock on MEXC

Eligible investors can buy real shares of Minerva Neurosciences, Inc. (NERV) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for NERV and Place Your Order

Open the RealStocks trading page and search for NERV. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Minerva Neurosciences, Inc. (NERV) share price today?

Minerva Neurosciences, Inc. (NERV) is currently trading at $ 2,54, down 12,11% ($0,35) from the previous close of $ 2,89. Intraday prices update in real time during regular trading hours.

2.Is NERV stock going up or down today?

As of 2026-10-13 17:23:00, NERV is trading at $ 2,54, down 12,11% ($0,35) from its previous close of $ 2,89. The stock has traded between $ 1,15 and $ 126,72 during today’s regular session. Past price movements do not guarantee future results.

3.What is NERV pre-market price?

As of 2026-10-13 17:23:00, NERV is trading at $ 2,89 in pre-market trading, down 0,17% ($0,01) from the previous close of $ 2,89. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is NERV after-hours price?

As of 2026-10-13 17:23:00, NERV is trading at $ 2,89 in after-hours trading, down 0,17% ($0,01) from the regular-session close of $ 2,89. After-hours prices may differ from the regular session's opening price due to lower liquidity and wider bid-ask spreads.

5.Is NERV stock trading now?

NERV trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does NERV sit relative to its 52-week high and low?

Over the past 52 weeks, NERV has traded between a low of $ 2,24 and a high of $ 12,46. At $ 2,54, the stock is positioned 3,0% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Minerva Neurosciences, Inc. in?

Minerva Neurosciences, Inc. (NERV) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Minerva Neurosciences, Inc.'s market capitalisation and where is it listed?

Minerva Neurosciences, Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 151,84M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is NERV valued in terms of P/E ratio and EPS?

NERV trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -8,28. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Minerva Neurosciences, Inc. pay a dividend?

Minerva Neurosciences, Inc. pays an indicated annual cash dividend of $ 0,00 per share, with a current dividend yield of 0,00% based on the latest share price. Dividend policies are subject to change at the board's discretion.